Few studies have examined the role of cathelicidin in the pathogenesis of T2DM, although LL-37 may help to control blood sugar levels, support the health of insulin-producing cells, and address COVID-19 complications linked to diabetes and hyperglycemia [63]. This evidence concerns the gene INS and Hyperglycemia.